Anemia and bone disease of chronic kidney disease: pathogenesis, diagnosis, and management

Area of Science:

• Nephrology
• Internal Medicine
• Bone Metabolism

Background:

• Anemia and metabolic bone disease are prevalent complications of chronic kidney disease (CKD).
• These conditions exacerbate morbidity and mortality in CKD patients.
• Their progression is closely linked to the advancement of kidney disease.

Purpose of the Study:

• To review the pathogenesis and diagnostic approaches for anemia in CKD.
• To review the pathogenesis and diagnostic approaches for metabolic bone disease in CKD.
• To summarize current consensus guidelines for the management of anemia and bone disease in CKD.

Main Methods:

• Literature review of anemia in CKD.
• Literature review of metabolic bone disease in CKD.
• Summary of recent international consensus guidelines.

Main Results:

• Anemia in CKD involves complex multifactorial causes.
• CKD-mineral and bone disorder (CKD-MBD) encompasses a spectrum of bone abnormalities.
• Current guidelines emphasize early diagnosis and tailored treatment strategies.

Conclusions:

• Integrated management of anemia and CKD-MBD is crucial for improving patient outcomes.
• Adherence to updated treatment guidelines can mitigate complications.
• Further research is needed to optimize therapeutic interventions.